105 results
Page 2 of 6
8-K
EX-1.1
dfowcrs40pxi2
21 Dec 23
Annexon Announces Pricing of $125.0 Million Underwritten Public Offering of Common Stock
4:09pm
424B5
m3zlug4
21 Dec 23
Prospectus supplement for primary offering
4:05pm
8-K
EX-99.1
fdzgmc2jhjid
13 Nov 23
Annexon Reports Significant Progress with its Priority Programs and Third Quarter 2023 Financial Results
4:10pm
8-K
EX-99.2
6btlb6rtjcbo73jdb
31 Jul 23
Annexon Biosciences Strengthens Leadership Team with Appointment of Jamie Dananberg, M.D., as Chief Medical Officer
4:30pm
8-K
ca8qtpfu3r8a5f9rlnju
9 Jun 23
Submission of Matters to a Vote of Security Holders
4:15pm
424B3
ojctjy
16 Nov 22
Prospectus supplement
4:26pm
S-3
EX-23.1
069ali8hax5 b7j009
4 Nov 22
Shelf registration
4:47pm
S-3
o4szbp4 rufn
4 Nov 22
Shelf registration
4:47pm
S-8
EX-23.2
jeynscd3qqf2v8rxl7y
8 Aug 22
Registration of securities for employees
5:24pm
S-8
0iyas gtgv
8 Aug 22
Registration of securities for employees
5:24pm
8-K
EX-10.1
ottj1
8 Jul 22
Annexon Announces $130 Million Private Placement Financing
5:19pm
8-K
EX-4.2
fhwrawr4e5
8 Jul 22
Annexon Announces $130 Million Private Placement Financing
5:19pm
8-K
EX-99.2
oiohimxnu8cygfsw7
8 Jul 22
Annexon Announces $130 Million Private Placement Financing
5:19pm